pJK_proNR2_LGK.1
(Plasmid
#81161)
-
PurposeExpresses levoglucosan kinase variant LGK.1 with promoter proNR2
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 81161 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepJK
-
Backbone manufacturerpET29 derivative
- Backbone size w/o insert (bp) 3582
- Total vector size (bp) 4899
-
Modifications to backboneRemoval of the T7 promoter, T7 operator, lacI gene. Addition of the constitutive promoter proJK1 between BglI and XbaI. LGK is between NdeI and XhoI.
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsRich media for plasmid production as the constitutive promoter will reduce production under minimal media.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameLevoglucosan kinase
-
Alt nameB3VI55_LIPST
-
SpeciesSynthetic; Lipomyces starkeyi
-
Insert Size (bp)1317
-
MutationLGK.1 (L140I,S142A,A373C)
-
GenBank IDACE79748.1 EU751287.1
- Promoter proNR2
-
Tag
/ Fusion Protein
- His6x (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer GGTGATTCATTCTGCTAA
- 3′ sequencing primer T7 Term (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pJK_proNR2_LGK.1 was a gift from Timothy Whitehead (Addgene plasmid # 81161 ; http://n2t.net/addgene:81161 ; RRID:Addgene_81161) -
For your References section:
Comprehensive sequence-flux mapping of a levoglucosan utilization pathway in E. coli. Klesmith JR, Bacik JP, Michalczyk R, Whitehead TA. ACS Synth Biol. 2015 Sep 14. 10.1021/acssynbio.5b00131 PubMed 26369947